S

Spoknwrd Clinical Trials Inc. | Easton, PA

Research site

(Unclaimed)

Location

3465 Nazareth Road, Easton, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

Pemigatinib

Dexamethasone

Pomalidomide

Sacituzumab

Isatuximab

Quizartinib

Epcoritamab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic Follicul...

Active, not recruiting

Classic Follicular Lymphoma

Diffuse Large B-Cell Lymphoma

Drug: Epcoritamab

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

This clinical two-arm trial is designed to evaluate two doses of quizartinib as maintenance therapy after induction/consolidation in participants wit...

Enrolling

Leukemia

Acute Myeloid Leukemia

Drug: Quizartinib Low Dose

Drug: Quizartinib High Dose

SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM (IRAKLIA)

This is a randomized, multicenter, Phase 3, open-label study evaluating subcutaneous (SC) vs intravenous (IV) administration of isatuximab in combina...

Active, not recruiting

Plasma Cell Myeloma Recurrent

Drug: Montelukast

Drug: Dexamethasone

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (EVOKE-SCLC-04)

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of ca...

Enrolling

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Drug: Topotecan

Drug: Sacituzumab Govitecan (SG)

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms